Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation - a retrospective study
- PMID: 30536448
- PMCID: PMC6850661
- DOI: 10.1111/tri.13387
Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation - a retrospective study
Abstract
Perioperative antithrombotic therapy could play a role in preventing thromboembolic complications (TEC) after kidney transplantation (KTx), but little is known on postoperative bleeding risks. This retrospective analysis comprises 2000 single-organ KTx recipients transplanted between 2011 and 2016 in the two largest transplant centers of the Netherlands. TEC and bleeding events were scored ≤7 days post-KTx. Primary analyses were for associations of antithrombotic therapy with incidence of TEC and bleeding. Secondary analyses were for associations of other potential risk factors. Mean age was 55 ± 14 years, 59% was male and 60% received a living donor kidney. Twenty-one patients (1.1%) had a TEC. Multiple donor arteries [OR 2.79 (1.15-6.79)] and obesity [OR 2.85 (1.19-6.82)] were identified as potential risk factors for TEC. Bleeding occurred in 88 patients (4.4%) and incidence varied significantly between different antithrombotic therapies (P = 0.006). Cardiovascular disease [OR 2.01 (1.18-3.42)], pre-emptive KTx [OR 2.23 (1.28-3.89)], postoperative heparin infusion [OR 1.69 (1.00-2.85)], and vitamin K antagonists [OR 6.60 (2.95-14.77)] were associated with an increased bleeding risk. Intraoperative heparin and antiplatelet therapy were not associated with increased bleeding risk. These regimens appear to be safe for the possible prevention of TEC without increasing the risk for bleeding after KTx.
Keywords: anticoagulation; bleeding; kidney transplant; risk factors; thrombosis.
© 2018 The Authors. Transplant International published by John Wiley & Sons Ltd on behalf of Steunstichting ESOT.
Conflict of interest statement
The authors have declared no conflicts of interest.
Figures
References
-
- Penny MJ, Nankivell BJ, Disney AP, Byth K, Chapman JR. Renal graft thrombosis. A survey of 134 consecutive cases. Transplantation 1994; 58: 565. - PubMed
-
- Bakir N, Sluiter WJ, Ploeg RJ, van Son WJ, Tegzess AM. Primary renal graft thrombosis. Nephrol Dial Transplant 1996; 11: 140. - PubMed
-
- Orlic P, Vukas D, Drescik I, et al Vascular complications after 725 kidney transplantations during 3 decades. Transplant Proc 2003; 35: 1381. - PubMed
-
- Garcia CD, Bittencourt VB, Pires F, et al Renal transplantation in children younger than 6 years old. Transplant Proc 2007; 39: 373. - PubMed
-
- Ojo AO, Hanson JA, Wolfe RA, et al Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. Kidney Int 1999; 55: 1952. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
